Showing results (751-760 of 835) with videos related to
Sort By:
Pageof 84
The Journal of Infectious Diseases|March 5, 2021
Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom-Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in AfricaElihu Aranday-Cortes, C Patrick McClure, Christopher Davis, et al.Pediatric Blood & Cancer|September 22, 2016
Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing programRichard Lock, Hernan Carol, John M Maris, et al.Pediatric Blood & Cancer|September 30, 2014
Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673Malcolm A Smith, Oliver A Hampton, C Patrick Reynolds, et al.Pediatric Blood & Cancer|July 2, 2013
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortiumBarry J Maurer, Min H Kang, Judith G Villablanca, et al.The American Journal of Emergency Medicine|September 16, 2009
A study of the workforce in emergency medicine: 2007Francis L Counselman, Catherine A Marco, Vicki C Patrick, et al.Human Vaccines & Immunotherapeutics|October 15, 2016
Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas diseaseChristopher A Seid, Kathryn M Jones, Jeroen Pollet, et al.Pediatric Blood & Cancer|September 17, 2011
Initial testing of JNJ-26854165 (Serdemetan) by the pediatric preclinical testing programMalcolm A Smith, Richard Gorlick, E Anders Kolb, et al.Pediatric Blood & Cancer|September 24, 2015
Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): A report from the pediatric preclinical testing programEdward F Attiyeh, John M Maris, Richard Lock, et al.Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|January 21, 2026
Pre-implementation Barriers and Facilitators to Integrating Complementary and Integrative Health Interventions into Clinic Workflow: The GRACE Trial, NIH Pragmatic Trials CollaboratoryStephanie O Ibemere, Mitchell R Knisely, Ivy Akpotu, et al.The New England Journal of Medicine|October 1, 2010
Outcome after reduced chemotherapy for intermediate-risk neuroblastomaDavid L Baker, Mary L Schmidt, Susan L Cohn, et al.Pageof 84